| Name | (5Z,8Z,11Z,14Z)-N,N-Bis(3-chloro-4-hydroxybenzyl)-5,8,11,14-icosatetraenamide |
|---|---|
| Synonyms |
5,8,11,14-Eicosatetraenamide, N,N-bis[(3-chloro-4-hydroxyphenyl)methyl]-, (5Z,8Z,11Z,14Z)-
(5Z,8Z,11Z,14Z)-N,N-Bis(3-chloro-4-hydroxybenzyl)icosa-5,8,11,14-tetraenamide (5Z,8Z,11Z,14Z)-N,N-Bis(3-chloro-4-hydroxybenzyl)-5,8,11,14-icosatetraenamide |
| Description | O-2093 is a selective endocannabinoid anandamide (AEA) reuptake inhibitor with IC50 of 17.3 μM[1]. |
|---|---|
| Related Catalog | |
| In Vivo | O-2093 (1 mg/kg, i.v.) 可显着抑制 CREATE 小鼠的肢体痉挛[1]。 |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 715.1±60.0 °C at 760 mmHg |
| Molecular Formula | C34H43Cl2NO3 |
| Molecular Weight | 584.62 |
| Flash Point | 386.3±32.9 °C |
| Exact Mass | 583.262024 |
| LogP | 9.69 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.579 |